Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors.
about
Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Body mass index does not impac ...... on tyrosine kinase inhibitors.
@en
Body mass index does not impac ...... on tyrosine kinase inhibitors.
@nl
type
label
Body mass index does not impac ...... on tyrosine kinase inhibitors.
@en
Body mass index does not impac ...... on tyrosine kinase inhibitors.
@nl
prefLabel
Body mass index does not impac ...... on tyrosine kinase inhibitors.
@en
Body mass index does not impac ...... on tyrosine kinase inhibitors.
@nl
P2093
P2860
P50
P356
P1476
Body mass index does not impac ...... on tyrosine kinase inhibitors.
@en
P2093
Daniela Diverio
Gioia Colafigli
Martina Canichella
Matteo Molica
P2860
P356
10.1111/BJH.14783
P407
P577
2017-07-05T00:00:00Z